BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 120396
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.120396
Table 1 Characteristics of study populations based on dialysis modality
Characteristic
PD (n = 43)
HD (n = 40)
P value
Age (year), mean (SD)41.14 (12.67)51.85 (11.06)< 0.0012,a
Male22 (51.2)21 (52.5)0.9031
Female21 (48.8)19 (47.5)
Cause of ESRD
    Diabetes5 (11.6)5 (12.5)0.9321
    Hypertension30 (69.8)24 (0.6)
    Unknown8 (18.6)10 (0.25)
Duration of dialysis, month40 (15; 52)35.5 (15.5; 64.5)0.4593
Hemoglobin, gr/dL8.32 (2.13)9.55 (2.26)0.0122,a
NLR4.02 (2.08)2.98 (1.77)0.0012,a
TSAT, %29 (23; 43)27 (23; 37.5)0.9432
Albumin, g/dL3.52 (0.69)2.98 (1.77)0.0682
Calcium, mg/dL7.72 (1.54)7.91 (5.81)0.0672
Phosphor, mg/dL4.55 (1.41)3.80 (2.20)0.8402
Calcium/phosphor product35.97 (12.34)35.02 (24.56)0.8212
Klotho, ng/mL6.12 (2.99; 9.11)5.30 (1.88; 8.36)0.2863
FGF-23, pg/mL132.26 (77.82; 312.93)148.66 (106.05; 457.42)0.1553
FGF-23/Klotho ratio26.06 (13.32; 69.45)67.34 (16.56; 131.35)0.0393,a
cIMT, mm0.53 (0.47; 0.63)0.63 (0.54; 0.70)0.0053,a
iPTH, pg/mL603.10 (347.00; 841.10)209.05 (110.55; 423.87)< 0.0013,a


Write to the Help Desk